longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Moderna

MRNA

138.7101.15% ( -1.620 )
Trading: Sep 9, 11:04:43 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is -17.78, below the reasonable range, cheaper than 99.16% of the time in the past 5 years, and the industry ranks 491/601, the industry Median -2.59.

-17.78xP/E
$140.33Stock price
$-7.89Earnings per share
-17.78xP/E
Stock price$140.33Earnings per share$-7.89

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-3.38x
Typical range
-7.52x–6.98x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
018365472

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-56.12x148.27%$181.83B
CSLLYUSCSL Limited
-23.43x--$60.44B
MRNAUSModerna
-17.78x15.79%$56.02B
NTRAUSNatera
-242.91x10.38%$46.72B
RVMDUSRevolution Medicines
-25.13x64.18%$44.44B
ROIVUSRoivant Sciences
-112.53x148.24%$29.96B
INSMUSInsmed
-31.16x74.55%$27.27B
BNTXUSBioNTech SE
-12.66x19.96%$24.78B
BBIOUSBridgebio Pharma
-21.12x28.75%$14.62B
SMMTUSSummit Therapeutics
-16.10x18.42%$13.79B
MDGLUSMadrigal Pharma
-37.96x50.86%$12.34B
ARWRUSArrowHead Pharma
-37.57x36,308.30%$12.02B
CYTKUSCytokinetics
-11.72x6.37%$10.48B
ABVXUSAbivax SA
-26.72x32.59%$10.37B
PRAXUSPraxis Precision Medicines
-29.02x3.05%$9.84B
KYMRUSKymera Therapeutics
-32.32x4.94%$9.68B
IONSUSIonis Pharma
-16.68x52.66%$9.42B
PCVXUSVaxcyte
-8.44x48.80%$8.98B
IBRXUSImmunityBio
-8.85x152.63%$8.79B
TWSTUSTwist Bioscience
-61.66x24.70%$8.43B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.